Aegera Therapeutics

Developing novel small molecule therapeutics against cancer and immune diseases

placeMontreal, Montreal, Canada calendar_todayFounded 2000 groups1,300 employees language aegera.com

Innovation

37 patent families (13 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace slowing. Cited 2,382 times.

YearFilings
20123
20132
20142
20152
20171
20221

Investor mix

12 investors on record.

Investor typeCountShare
Venture capital542%
Private equity18%
Other / undisclosed650%
Coming soon